Antalpha Ventures, Web3Labs, and Goldford-HB Launch Computational Power Fund for AI and Web3 Projects
Antalpha Ventures, a global investment firm at the forefront of cutting-edge technology, has partnered with renowned Asian Web3 incubator Web3Labs and venture capital firm Goldford-HB to launch a new computational power fund. This fund aims to support early to mid-stage AI and Web3 projects worldwide by providing the necessary computational resources.
Fund Background
In today’s digital economy, artificial intelligence (AI) is a major driver of growth, with computational power emerging as the new “energy.” The demand for computational resources in AI training, inference, and other processes has surged, leading to rising costs. Recognizing these challenges, Antalpha Ventures, Web3Labs, and Goldford-HB have established this fund to assist emerging AI companies in overcoming these hurdles.
By leveraging our extensive computational power, along with our robust AI and Web3 networks and partnerships, we aim to incubate and accelerate high-quality, innovative AI and AI-related Web3 projects. Our computational power fund is designed to support early-stage projects, particularly those requiring significant computational resources, such as AI-generated content (AIGC) for text, images, and videos, as well as computational power platforms. This support will help projects reduce the high computational costs typically associated with the early stages of development.
Available Computational Power
The computational power fund from Antalpha Ventures, Web3Labs, and Goldford-HB will invest primarily through the provision of computational resources, valued at tens of millions of dollars. Our infrastructure is tailored for low-latency, high-processing-demand applications, including AI/ML training, inference, operations, and cloud gaming. The fund aims to democratize access to computational power, offering more options for engineers and businesses alike.
Project Requirements
We are seeking innovative projects in the following areas:
- Application-based projects with high computational power needs, including AI-generated text, images, and videos.
- Decentralized computational power platforms, focusing on AI training and inference.
- Other Web3+AI projects with related computational power requirements.
Priority will be given to teams with strong backgrounds and prior success in related fields.
For more information on how to apply, please email us at [email protected] or clicked in for more details ( https://mp.weixin.qq.com/s/Sq1MEki8WKjp8MjsYfPEiQ )
Related Posts
” E-Tronic(Guangzhou) Technology” completes Series A financing led by Infinity Capital
E-Tronic(Guangzhou)Technology Co.，Ltd., a provider of power semiconductors and system solutions for new energy vehicles, has completed its Series A financing with a cumulative amount of over 100 million RMB. This round of financing was led by Infinity Capital, with additional investment from old shareholders Zhongnan Venture Capital and Guangzhou Development
MDHC Technologies Secures Series B Funding to Accelerate Growth and Innovation (2024)
MDHC Technologies completed a Series B funding round with investors including Chery Automobile, LAKSIMI Capital, Lucion Venture Capital Group, Yongxin Fangzhou, Addor Capital, and others. The funding will accelerate the development of its intelligent manufacturing platform, expand production capacity, and increase R&D investment, driving innovation and mark
Leto Laboratories Completes Series C Financing of Over 100 Million RMB, Focusing on 0 to 1 Innovative Protein Design and Manufacturing Platform Construction
Leto Laboratories announced the completion of its Series C financing round with a funding size of over 100 million RMB. This round of financing was led by Zhongguancun Science City Corporation and followed by Infiniti Capital and HB Ventures. The round was mainly used for the clinical research of LTC004, a new-generation anti-tumor cytokine class […]
FDA Approves IND for LAE120, a Novel USP1 Inhibitor for Advanced Solid Tumors (March 4, 2025)
In March 2025, Laekna announced that the FDA approved the IND for LAE120, a novel USP1 inhibitor developed internally for advanced solid tumors. LAE120 shows potent monotherapy anti-tumor activity and synergy with PARP inhibitors, especially in homologous recombination deficiency (HRD) cancers. It demonstrated strong tumor inhibition in various xenograft models